The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al.

COVID-19 in kidney transplant recipients

(2020) Ilaria Gandolfini et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy

(2020) Paola Toniati et al.   AUTOIMMUNITY REVIEWS

Colchicine may not be effective in COVID-19 infection; it may even be harmful?

(2020) Medine Cumhur Cure et al.   CLINICAL RHEUMATOLOGY

Endothelial cell infection and endotheliitis in COVID-19

(2020) Zsuzsanna Varga et al.   LANCET

COVID-19: consider cytokine storm syndromes and immunosuppression

(2020) Puja Mehta et al.   LANCET

Colchicine therapy for deep vein thrombosis in a patient with vascular-type Behçet disease

(2020) Daishi Nonaka et al.   MEDICINE

Why not to use colchicine in COVID-19? An old anti-inflammatory drug for a novel auto-inflammatory disease

(2020) Silvia Piantoni et al.   RHEUMATOLOGY

Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome

(2019) I-Yin Chen et al.   Frontiers in Microbiology

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction

(2019) Jean-Claude Tardif et al.   NEW ENGLAND JOURNAL OF MEDICINE

Neutrophil Activation Promotes Fibrinogen Oxidation and Thrombus Formation in Behçet's Disease

(2015) Matteo Becatti et al.   CIRCULATION

Colchicine—Update on mechanisms of action and therapeutic uses

(2015) Ying Ying Leung et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM